153 related articles for article (PubMed ID: 25616963)
1. A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity.
Chen D; Gaborieau V; Zhao Y; Chabrier A; Wang H; Waterboer T; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Bencko V; Janout V; Foretova L; Mates IN; Szeszenia-Dabrowska N; Boffetta P; Pawlita M; Lathrop M; Gyllensten U; Brennan P; McKay JD
Hum Mol Genet; 2015 May; 24(9):2681-8. PubMed ID: 25616963
[TBL] [Abstract][Full Text] [Related]
2. Imputing amino acid polymorphisms in human leukocyte antigens.
Jia X; Han B; Onengut-Gumuscu S; Chen WM; Concannon PJ; Rich SS; Raychaudhuri S; de Bakker PI
PLoS One; 2013; 8(6):e64683. PubMed ID: 23762245
[TBL] [Abstract][Full Text] [Related]
3. Identification of two independent risk factors for lupus within the MHC in United Kingdom families.
Fernando MM; Stevens CR; Sabeti PC; Walsh EC; McWhinnie AJ; Shah A; Green T; Rioux JD; Vyse TJ
PLoS Genet; 2007 Nov; 3(11):e192. PubMed ID: 17997607
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study of HPV seropositivity.
Chen D; McKay JD; Clifford G; Gaborieau V; Chabrier A; Waterboer T; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Bencko V; Janout V; Foretova L; Mates IN; Szeszenia-Dabrowska N; Curado MP; Koifman S; Menezes A; Wünsch-Filho V; Eluf-Neto J; Fernández Garrote L; Matos E; Zelenika D; Boland A; Boffetta P; Pawlita M; Lathrop M; Brennan P
Hum Mol Genet; 2011 Dec; 20(23):4714-23. PubMed ID: 21896673
[TBL] [Abstract][Full Text] [Related]
5. Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.
Rubio JP; Bahlo M; Butzkueven H; van Der Mei IA; Sale MM; Dickinson JL; Groom P; Johnson LJ; Simmons RD; Tait B; Varney M; Taylor B; Dwyer T; Williamson R; Gough NM; Kilpatrick TJ; Speed TP; Foote SJ
Am J Hum Genet; 2002 May; 70(5):1125-37. PubMed ID: 11923913
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
7. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
8. Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.
Adebamowo SN; Adeyemo AA;
Hum Immunol; 2019 Sep; 80(9):723-730. PubMed ID: 31072753
[TBL] [Abstract][Full Text] [Related]
9. Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.
Zhang C; de Smith AJ; Smirnov IV; Wiencke JK; Wiemels JL; Witte JS; Walsh KM
J Neurooncol; 2017 Nov; 135(2):237-244. PubMed ID: 28721485
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping the MHC region in Asian populations identified novel variants modifying susceptibility to lung cancer.
Qin N; Wang C; Zhu M; Lu Q; Ma Z; Huang M; Dai J; Ma H; Jin G; Hu Z; Shen H
Lung Cancer; 2017 Oct; 112():169-175. PubMed ID: 29191591
[TBL] [Abstract][Full Text] [Related]
11. Association of Parkinson disease with structural and regulatory variants in the HLA region.
Wissemann WT; Hill-Burns EM; Zabetian CP; Factor SA; Patsopoulos N; Hoglund B; Holcomb C; Donahue RJ; Thomson G; Erlich H; Payami H
Am J Hum Genet; 2013 Nov; 93(5):984-93. PubMed ID: 24183452
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.
Hu JM; Sun Q; Li L; Liu CX; Chen YZ; Zou H; Pang LJ; Zhao J; Yang L; Cao YW; Cui XB; Qi Y; Liang WH; Zhang WJ; Li F
Int J Clin Exp Pathol; 2014; 7(9):6165-71. PubMed ID: 25337265
[TBL] [Abstract][Full Text] [Related]
13. HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection.
Ferrera A; Olivo A; Alaez C; Melchers WJ; Gorodezky C
Hum Biol; 1999 Jun; 71(3):367-79. PubMed ID: 10380373
[TBL] [Abstract][Full Text] [Related]
14. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.
Kohaar I; Hussain S; Thakur N; Tiwari P; Nasare V; Batra S; Singh V; Bhambani S; Das BC; Sarkar DP; Bharadwaj M
Hum Immunol; 2009 Apr; 70(4):222-9. PubMed ID: 19272325
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.
Lesseur C; Diergaarde B; Olshan AF; Wünsch-Filho V; Ness AR; Liu G; Lacko M; Eluf-Neto J; Franceschi S; Lagiou P; Macfarlane GJ; Richiardi L; Boccia S; Polesel J; Kjaerheim K; Zaridze D; Johansson M; Menezes AM; Curado MP; Robinson M; Ahrens W; Canova C; Znaor A; Castellsagué X; Conway DI; Holcátová I; Mates D; Vilensky M; Healy CM; Szeszenia-Dąbrowska N; Fabiánová E; Lissowska J; Grandis JR; Weissler MC; Tajara EH; Nunes FD; de Carvalho MB; Thomas S; Hung RJ; Peters WH; Herrero R; Cadoni G; Bueno-de-Mesquita HB; Steffen A; Agudo A; Shangina O; Xiao X; Gaborieau V; Chabrier A; Anantharaman D; Boffetta P; Amos CI; McKay JD; Brennan P
Nat Genet; 2016 Dec; 48(12):1544-1550. PubMed ID: 27749845
[TBL] [Abstract][Full Text] [Related]
16. Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levels.
Ramachandran D; Schürmann P; Mao Q; Wang Y; Bretschneider LM; Speith LM; Hülse F; Enßen J; Bousset K; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Tarbiat J; Runnebaum I; Dürst M; Hein A; Koch M; Ruebner M; Ekici A; Beckmann MW; Fasching PA; Luyten A; Petry KU; Hillemanns P; Dörk T
Int J Cancer; 2020 Nov; 147(9):2458-2468. PubMed ID: 32580243
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
18. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer.
de Araujo Souza PS; Maciag PC; Ribeiro KB; Petzl-Erler ML; Franco EL; Villa LL
BMC Cancer; 2008 Aug; 8():246. PubMed ID: 18721466
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility factors of Type 1 diabetes in Asians.
Park Y; Eisenbarth GS
Diabetes Metab Res Rev; 2001; 17(1):2-11. PubMed ID: 11241886
[TBL] [Abstract][Full Text] [Related]
20. HLA polymorphisms and cervical human Papillomavirus infection in a cohort of Montreal University students.
Mahmud SM; Robinson K; Richardson H; Tellier PP; Ferenczy AS; Roger M; Coutlee F; Franco EL
J Infect Dis; 2007 Jul; 196(1):82-90. PubMed ID: 17538887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
